ANADAY TABLET – Composition, Uses and Medicine Enquiries
Product Overview
ANADAY TABLET is a product listed under the anticancer category as an aromatase inhibitor. Its active composition is Anastrozole 1 mg. It is associated with hormone receptor-positive breast cancer in postmenopausal women.
The product reduces estrogen production by blocking aromatase activity. Suitability depends on the diagnosis, approved labeling, clinical history and specialist assessment.
This information is provided for education and product identification, not as a recommendation to begin treatment. The product should be considered only when the patient’s tumor characteristics and menopausal status support this type of therapy. A qualified clinician should confirm whether this exact brand, strength and formulation are appropriate before any prescription or treatment decision.
Composition and Strength
| Product Detail | Information |
|---|---|
| Product Name | ANADAY TABLET |
| Generic Name | Anastrozole |
| Brand Name | ANADAY |
| Strength | 1 mg |
Therapeutic Category and Indication
Therapeutic Category: Anticancer
Medicine Class: Aromatase inhibitor
Associated Indication: Hormone receptor-positive breast cancer in postmenopausal women
The principal clinical use associated with ANADAY TABLET is hormone receptor-positive breast cancer in postmenopausal women. Its active ingredient reduces estrogen production by blocking aromatase activity.
Treatment eligibility may depend on diagnostic tests, organ function, other medicines and the relevant national prescribing information. The original spreadsheet category or indication may not accurately represent the brand-specific approval. A qualified pharmacist should check the approved product label before publication.
The product should be considered only when the patient’s tumor characteristics and menopausal status support this type of therapy.
Administration Information
The supplied product information states that ANADAY TABLET is taken orally and consistently as directed by the oncology team.
Follow the exact prescribed route, dose and schedule. Do not change, share or discontinue this medicine without the treating professional’s advice. Review the manufacturer’s patient instructions.
Product Presentation and Availability
- Product: ANADAY TABLET
- Active Composition: Anastrozole 1 mg
- Manufacturer/Marketer listed in the spreadsheet: Zuventus Healthcare Ltd
- Pack Size: Requires verification
- Dosage Form and Current Labeling: Confirm from the actual manufacturer pack
The manufacturer/marketer attribution, current pack size, dosage form, labeling, batch details and expiry must be independently verified. No particular packaging, stock or delivery is promised by Medinglobal.
Prescription and Patient Safety
ANADAY TABLET is associated with hormone receptor-positive breast cancer in postmenopausal women. Treatment suitability depends on the patient’s diagnosis, tumor characteristics and menopausal status.
The product should only be considered when the patient’s tumor and menopausal status support this type of therapy. A qualified clinician must assess whether the exact product is appropriate.
This information is for education and product identification only, not a recommendation to begin treatment.
Medicine Enquiry Coordination Through Medinglobal
Medinglobal receives enquiries about ANADAY TABLET and may coordinate requests for product information with independent, appropriately authorized pharmaceutical providers.
Medinglobal is not the manufacturer, direct seller, dispensing pharmacy or exporter of this product. Any permitted transaction, prescription check, destination-country assessment, supply terms and supporting documentation are handled by the relevant authorized provider.
An enquiry does not guarantee availability or supply.
How to Submit an ANADAY TABLET Enquiry
Submit the following details through Medinglobal’s medicine enquiry channel:
- Product name: ANADAY TABLET
- Strength: Anastrozole 1 mg
- Required formulation
- Required quantity
- Destination country
Include a valid prescription or institutional documents when required. Medinglobal may connect the enquiry with an appropriately authorized independent provider, which must independently confirm legality, product identity and any applicable commercial terms.
Frequently Asked Questions
What is ANADAY TABLET used for?
It is associated with hormone receptor-positive breast cancer in postmenopausal women, subject to the exact approved label and medical assessment.
What does ANADAY TABLET contain?
It contains Anastrozole 1 mg. Confirm the final composition on the manufacturer pack.
How is ANADAY TABLET administered?
The supplied information states that it is taken orally and consistently as directed by the oncology team.
Can I request product information through Medinglobal?
Yes. Medinglobal can receive a coordination enquiry. Supply is neither guaranteed nor directly undertaken by Medinglobal.




Reviews
There are no reviews yet.